Activin-ActRII antagonists and uses for increasing red blood cell levels

Details for Australian Patent Application No. 2007334333 (hide)

Owner Acceleron Pharma Inc.

Inventors Sherman, Matthew L.

Agent Shelston IP

Pub. Number AU-A-2007334333

PCT Pub. Number WO2008/076437

Priority 60/875,682 18.12.06 US

Filing date 18 December 2007

Wipo publication date 26 June 2008

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/076437 Priority application(s): WO2008/076437

12 May 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 28 Mar 2011 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007334339-Combination therapy for treating hepatitis C infections

2007334331-Muscle derived cells for the treatment of gastro-esophageal pathologies and methods of making and using the same